Literature DB >> 11398792

Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor.

S Kapur, P Seeman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11398792     DOI： 10.1016/s0006-3223(01)01110-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  10 in total

Review 1.  Neurochemical modulators of sleep and anesthetic states.

Authors:  Christa J Van Dort; Helen A Baghdoyan; Ralph Lydic
Journal:  Int Anesthesiol Clin       Date:  2008

Review 2.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

3.  Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.

Authors:  Sargo Aalto; Jouni Ihalainen; Jussi Hirvonen; Jaana Kajander; Harry Scheinin; Heikki Tanila; Kjell Någren; Harry Vilkman; Lars L Gustafsson; Erkka Syvälahti; Jarmo Hietala
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

4.  Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.

Authors:  André Schmidt; Rosilla Bachmann; Michael Kometer; Philipp A Csomor; Klaas E Stephan; Erich Seifritz; Franz X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

5.  Distinct effects of ketamine and acetyl L-carnitine on the dopamine system in zebrafish.

Authors:  Bonnie L Robinson; Melanie Dumas; Elvis Cuevas; Qiang Gu; Merle G Paule; Syed F Ali; Jyotshna Kanungo
Journal:  Neurotoxicol Teratol       Date:  2016-02-16       Impact factor: 3.763

6.  Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.

Authors:  N Lally; A C Nugent; D A Luckenbaugh; R Ameli; J P Roiser; C A Zarate
Journal:  Transl Psychiatry       Date:  2014-10-14       Impact factor: 6.222

7.  Urothelial toxicity of esketamine in the treatment of depression.

Authors:  Hannelore Findeis; Cathrin Sauer; Anthony Cleare; Michael Bauer; Philipp Ritter
Journal:  Psychopharmacology (Berl)       Date:  2020-07-26       Impact factor: 4.530

8.  A computational lens on menopause-associated psychosis.

Authors:  Victoria L Fisher; Liara S Ortiz; Albert R Powers
Journal:  Front Psychiatry       Date:  2022-08-03       Impact factor: 5.435

Review 9.  From drugs to deprivation: a Bayesian framework for understanding models of psychosis.

Authors:  P R Corlett; C D Frith; P C Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2009-05-28       Impact factor: 4.530

10.  Biosensors Show the Pharmacokinetics of S-Ketamine in the Endoplasmic Reticulum.

Authors:  Kallol Bera; Aron Kamajaya; Amol V Shivange; Anand K Muthusamy; Aaron L Nichols; Philip M Borden; Stephen Grant; Janice Jeon; Elaine Lin; Ishak Bishara; Theodore M Chin; Bruce N Cohen; Charlene H Kim; Elizabeth K Unger; Lin Tian; Jonathan S Marvin; Loren L Looger; Henry A Lester
Journal:  Front Cell Neurosci       Date:  2019-11-12       Impact factor: 5.505
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.